ERManI Is a Target of miR-125b and Promotes Transformation Phenotypes in Hepatocellular Carcinoma (HCC)

Por Pan, Shujuan, Cheng, Xiaoyun, Chen, Hongan, Castro, Patricia D., Ittmann, Michael M., Hutson, Anne W., Zapata, Susan K., Sifers, Richard N.
Publicado em 2013

Correction: ERManI Is a Target of miR-125b and Promotes Transformation Phenotypes in Hepatocellular Carcinoma (HCC)

Por Pan, Shujuan, Cheng, Xiaoyun, Chen, Hongan, Castro, Patricia D., Ittmann, Michael M., Hutson, Anne W., Zapata, Susan K., Sifers, Richard N.
Publicado em 2014